Morton D L, Eilber F R, Townsend C M, Grant T T, Mirra J, Weisenburger T H
Ann Surg. 1976 Sep;184(3):268-78. doi: 10.1097/00000658-197609000-00004.
Multimodality management of extremity skeletal and soft tissue sarcomas with preoperative intra-arterial Adriamycin and radiation therapy, radical surgical resection and postoperative chemotherapy or chemo-immunotherapy has resulted in preservation of a functional extremity in 13 or 14 patients. Seven of 8 patients with Stage IIIA and IIIB soft tissue sarcomas, managed with preoperative intra-arterial Adriamycin and radiation therapy, followed by en bloc soft tissue resection and 6 patients with bone sarcomas managed by preoperative treatment, followed by bone resection and replacement with cadaver bone allografts, remained free of disease from 4 to 34 months. The results of the combined modality approach were significantly better than the results obtained in patients managed by surgical resection alone, or by combination of operation with another single modality, both in terms of short term-recurrence free survival and salvage of a functional extremity.
采用术前动脉内注射阿霉素和放射治疗、根治性手术切除以及术后化疗或化学免疫疗法对肢体骨骼和软组织肉瘤进行多模式管理,已使13或14例患者的肢体功能得以保留。8例IIIA期和IIIB期软组织肉瘤患者中的7例,采用术前动脉内注射阿霉素和放射治疗,随后进行整块软组织切除;6例骨肉瘤患者采用术前治疗,随后进行骨切除并用尸体骨同种异体移植进行替代,这些患者在4至34个月内均无疾病复发。无论是在短期无复发生存率还是在保留肢体功能方面,联合治疗方法的效果均明显优于单纯手术切除或手术与另一种单一治疗方法联合治疗的患者。